BioCorRx (BICX) Invested Capital (2016 - 2025)
BioCorRx (BICX) has disclosed Invested Capital for 16 consecutive years, with -$6.4 million as the latest value for Q4 2025.
- Quarterly Invested Capital rose 17.58% to -$6.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.4 million through Dec 2025, up 17.58% year-over-year, with the annual reading at -$6.4 million for FY2025, 17.58% up from the prior year.
- Invested Capital hit -$6.4 million in Q4 2025 for BioCorRx, down from -$37828.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $11.8 million in Q1 2025 to a low of -$8.8 million in Q1 2023.
- Historically, Invested Capital has averaged -$4.6 million across 5 years, with a median of -$6.1 million in 2023.
- Biggest five-year swings in Invested Capital: crashed 284.58% in 2022 and later surged 270.37% in 2025.
- Year by year, Invested Capital stood at -$6.9 million in 2021, then grew by 29.22% to -$4.9 million in 2022, then dropped by 26.22% to -$6.1 million in 2023, then decreased by 27.53% to -$7.8 million in 2024, then grew by 17.58% to -$6.4 million in 2025.
- Business Quant data shows Invested Capital for BICX at -$6.4 million in Q4 2025, -$37828.0 in Q3 2025, and $11.8 million in Q1 2025.